Restore Mind Medicine

We Are Aligned with Shareholders Dr. Freeman owns 2.5% of Mind Med's shares, FCM beneficially owns an additional 1%. Both Dr. Freeman and Mr. Jain have invested over $1M of personal funds into the Company. FCM represents original shareholders of MindMed who are committed to long-term shareholder value. FCM, Dr. Freeman, Mr. Jain, and Mr. Freeman have pledged to lock-up their shares until June 2025, if FCM's slate is elected. FCM's nominees will not take RSUS. Only non-premium based stock options. Management will be incentivized to benefit only if they create durable shareholder value - no RSUS. 22

View entire presentation